Silence Therapeutics plc
SLN
$5.35
-$0.11-2.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 114.16M | 136.53M | 147.33M | 172.89M | 189.06M |
| Total Receivables | 20.04M | 16.84M | 26.91M | 22.19M | 18.37M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 13.12M | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.36M | 16.42M | -- | 16.03M | 15.47M |
| Total Current Assets | 148.55M | 169.79M | 187.37M | 211.11M | 222.90M |
|
|
|||||
| Total Current Assets | 148.55M | 169.79M | 187.37M | 211.11M | 222.90M |
| Net Property, Plant & Equipment | 1.83M | 1.80M | 1.98M | 2.21M | 2.13M |
| Long-term Investments | 10.62M | 9.78M | 9.39M | 10.10M | 9.68M |
| Goodwill | 10.62M | 9.78M | 9.39M | 10.10M | 9.68M |
| Total Other Intangibles | 317.00K | 310.00K | 312.00K | 345.80K | 337.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.91M | 3.61M | 3.59M | 2.87M | 2.98M |
| Total Assets | 165.23M | 185.30M | 202.64M | 227.02M | 238.40M |
|
|
|||||
| Total Accounts Payable | 14.31M | 18.81M | 3.70M | 19.13M | 18.95M |
| Total Accrued Expenses | -- | -- | 12.05M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 60.00K | 117.00K | 186.30K | 232.50K |
| Total Finance Division Other Current Liabilities | 457.00K | 392.00K | 958.00K | 3.35M | 3.50M |
| Total Other Current Liabilities | 457.00K | 392.00K | 958.00K | 3.35M | 3.50M |
| Total Current Liabilities | 14.77M | 19.26M | 16.82M | 22.67M | 22.67M |
|
|
|||||
| Total Current Liabilities | 14.77M | 19.26M | 16.82M | 22.67M | 22.67M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 56.31M | 53.29M | 51.79M | 77.68M | 73.54M |
| Total Liabilities | 71.08M | 72.56M | 68.61M | 100.35M | 96.21M |
|
|
|||||
| Common Stock & APIC | 625.40M | 623.36M | 619.85M | 495.80M | 459.89M |
| Retained Earnings | -531.25M | -510.62M | -485.83M | -464.61M | -404.60M |
| Treasury Stock & Other | -- | -- | -- | 95.50M | 86.90M |
| Total Common Equity | 94.16M | 112.74M | 134.02M | 126.68M | 142.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 94.16M | 112.74M | 134.02M | 126.68M | 142.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 94.16M | 112.74M | 134.02M | 126.68M | 142.19M |
|
|
|||||